1.Liu R, Luo Q, You W, Jin M. MicroRNA–106 attenuates hyperglycemia-induced vascular endothelial cell dysfunction by targeting HMGB1. Gene. 2018;677:142–8.
2.O’Keefe JH, Bell DS. Postprandial hyperglycemia/hyperlipidemia (postprandial dysmetabolism) is a cardiovascular risk factor. The American journal of cardiology. 2007;100(5):899–904.
3.Colette C, Monnier L. Acute glucose fluctuations and chronic sustained hyperglycemia as risk factors for cardiovascular diseases in patients with type 2 diabetes. Hormone and metabolic research. 2007;39(09):683–6.
4.Piqueras L, Reynolds AR, Hodivala-Dilke KM, Alfranca An, Redondo JM, Hatae T, et al. Activation of PPARβ/δ induces endothelial cell proliferation and angiogenesis. Arteriosclerosis, thrombosis, and vascular biology. 2007;27(1):63–9.
5.Mineo C, Deguchi H, Griffin JH, Shaul PW. Endothelial and antithrombotic actions of HDL. Circulation research. 2006;98(11):1352–64.
6.Di Tomo P, Lanuti P, Di Pietro N, Baldassarre MPA, Marchisio M, Pandolfi A, et al. Liraglutide mitigates TNF-alpha induced pro-atherogenic changes and microvesicle release in HUVEC from diabetic women. 2017;33(8).
7.Ambra R, Manca S, Palumbo MC, Leoni G, Natarelli L, De Marco A, et al. Transcriptome analysis of human primary endothelial cells (HUVEC) from umbilical cords of gestational diabetic mothers reveals candidate sites for an epigenetic modulation of specific gene expression. Genomics. 2014;103(5–6):337–48.
8.Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic acids research. 2015;43(7):e47.
9.Li H, Zhao X, Wang J, Zong M, Yang H. Bioinformatics analysis of gene expression profile data to screen key genes involved in pulmonary sarcoidosis. Gene. 2017;596:98–104.
10.Ni M, Liu X, Wu J, Zhang D, Tian J, Wang T, et al. Identification of Candidate Biomarkers Correlated With the Pathogenesis and Prognosis of Non-small Cell Lung Cancer via Integrated Bioinformatics Analysis. Frontiers in genetics. 2018;9:469.
11.Tang L, Cheng Y, Zhu C, Yang C, Liu L, Zhang Y, et al. Integrative methylome and transcriptome analysis to dissect key biological pathways for psoriasis in Chinese Han population. Journal of dermatological science. 2018;91(3):285–91.
12.Wang J, Zhang C, He W, Gou X. Construction and comprehensive analysis of dysregulated long non-coding RNA-associated competing endogenous RNA network in clear cell renal cell carcinoma. 2018.
13.Wils J, Favre J, Bellien J. Modulating putative endothelial progenitor cells for the treatment of endothelial dysfunction and cardiovascular complications in diabetes. Pharmacology & therapeutics. 2017;170:98–115.
14.Zhu ML, Yin YL, Ping S, Yu HY, Wan GR, Jian X, et al. Berberine promotes ischemia-induced angiogenesis in mice heart via upregulation of microRNA–29b. Clinical and experimental hypertension (New York, NY: 1993). 2017;39(7):672–9.
15.Gustafson D, Veitch S, Fish JE. Extracellular Vesicles as Protagonists of Diabetic Cardiovascular Pathology. Frontiers in cardiovascular medicine. 2017;4:71.
16.Targher G, Lonardo A, Byrne CD. Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus. Nature Reviews Endocrinology. 2018;14(2):99.
17.Kay AM, Simpson CL, Stewart JA. The role of AGE/RAGE signaling in diabetes-mediated vascular calcification. Journal of diabetes research. 2016;2016.
18.De Nigris V, Pujadas G, La Sala L, Testa R, Genovese S, Ceriello A. Short-term high glucose exposure impairs insulin signaling in endothelial cells. Cardiovascular diabetology. 2015;14:114.
19.Tabit CE, Chung WB, Hamburg NM, Vita JA. Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications. Reviews in Endocrine and Metabolic Disorders. 2010;11(1):61–74.
20.Leask A. Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation. Circulation research. 2010;106(11):1675–80.
21.Chen S, Puthanveetil P, Feng B, Matkovich SJ, Dorn GW, 2nd, Chakrabarti S. Cardiac miR–133a overexpression prevents early cardiac fibrosis in diabetes. Journal of cellular and molecular medicine. 2014;18(3):415–21.
22.Falcao-Pires I, Leite-Moreira AF. Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment. Heart failure reviews. 2012;17(3):325–44.
23.Engelsvold DH, Utheim TP, Olstad OK, Gonzalez P, Eidet JR, Lyberg T, et al. miRNA and mRNA expression profiling identifies members of the miR–200 family as potential regulators of epithelial-mesenchymal transition in pterygium. Experimental eye research. 2013;115:189–98.
24.Liang W, Xie Z, Cui W, Guo Y, Xu L, Wu J, et al. Comprehensive gene and microRNA expression profiling reveals a role for miRNAs in the oncogenic roles of SphK1 in papillary thyroid cancer. Journal of cancer research and clinical oncology. 2017;143(4):601–11.
25.Gong J, Wang ZX, Liu ZY. miRNA1271 inhibits cell proliferation in neuroglioma by targeting fibronectin 1. Molecular medicine reports. 2017;16(1):143–50.
26.Duan J, Zhang X, Zhang S, Hua S, Feng Z. miR–206 inhibits FN1 expression and proliferation and promotes apoptosis of rat type II alveolar epithelial cells. Experimental and therapeutic medicine. 2017;13(6):3203–8.